HF
PPH icon

HRT Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History

HRT Financial’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-55,225
Closed -$5.74M – 5102
2026
Q1 		$5.74M Buy
+55,225
New +$5.88M 0.01% 913
2025
Q2 		– Sell
-2,380
Closed -$216K – 3349
2025
Q1 		$216K Sell
2,380
-3,198
-57% -$288K ﹤0.01% 1970
2024
Q4 		$481K Buy
+5,578
New +$505K ﹤0.01% 1462
2024
Q3 		– Sell
-8,031
Closed -$734K – 2984
2024
Q2 		$734K Buy
+8,031
New +$717K ﹤0.01% 1137
2024
Q1 		– Sell
-46,430
Closed -$3.78M – 2916
2023
Q4 		$3.78M Buy
46,430
+18,884
+69% +$1.48M 0.03% 401
2023
Q3 		$2.2M Buy
+27,546
New +$2.22M 0.02% 579
2023
Q2 		– Sell
-67,098
Closed -$5.21M – 3095
2023
Q1 		$5.21M Buy
67,098
+62,036
+1,226% +$4.78M 0.06% 252
2022
Q4 		$393K Sell
5,062
-40,941
-89% -$3.02M 0.01% 1577
2022
Q3 		$3.09M Buy
46,003
+2,952
+7% +$217K 0.03% 451
2022
Q2 		$3.31M Buy
+43,051
New +$3.36M 0.04% 377

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

HRT Financial's PPH Position: Q2 2026 in Review

HRT Financial sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2026, closing a stake of 55,225 shares — an estimated $5.74M sold.

HRT Financial first reported a position in PPH in Q2 2022 and held it in 10 quarters. The position peaked at $5.74M in Q1 2026. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • HRT Financial reported no remaining VanEck Pharmaceutical ETF position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 55,225 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $5.74M.
  • HRT Financial first reported a position in VanEck Pharmaceutical ETF in Q2 2022 and held it in 10 quarters.
  • HRT Financial's VanEck Pharmaceutical ETF position peaked at $5.74M in Q1 2026.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.